Actualités

“Cyclophilin A, a novel target in cardiovascular disease: roles in redox signaling and inflammation” Invited by Alain Tedgui

“Targeting the microbial pharmacists within us to lower blood pressure” Invited by Rachel Climie

L’indoléamine 2, 3-dioxygénase (IDO) est une enzyme surexprimée chez les personnes atteintes d’obésité, de diabète ou encore d’hypercholestérolémie. Une série d’expériences menées chez la souris indique que son activité, associée à un microbiote intestinal particulier, serait directement responsable de l’apparition de ces troubles. article entier  

“Sofinnova Partners: historique, présentation générale et stratégie d’investissement”

Pr. Loupy was awarded in 2018 by the French National Academy of Medicine for his work in kidney transplantation, graft rejection by anti-HLA Donor Specific Antibodies and biomarker discovery. More details here

“Skeletal muscle energetics and exercise intolerance in heart failure: maybe more than the heart is failing?” Invited by Bertrand Tavitian

“The THINKER Trial: Transplanting Hepatitis C-infected Kidneys into Uninfected Recipients” Invited by Alexandre Loupy